Thirdly, using genetic instruments at the PCSK9 locus extracted from a GWAS of LDL-c, liver-derived PCSK9 expression, and circulating PCSK9 protein, this work focuses on the indirect association between PCSK9 inhibition and prostate cancer risk. Here, PCSK9 is linked to Familial prostate cancer.